These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2581140)

  • 1. Transient reversion of ras oncogene-induced cell transformation by antibodies specific for amino acid 12 of ras protein.
    Feramisco JR; Clark R; Wong G; Arnheim N; Milley R; McCormick F
    Nature; 1985 Apr 18-24; 314(6012):639-42. PubMed ID: 2581140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies specific for amino acid 12 of the ras oncogene product inhibit GTP binding.
    Clark R; Wong G; Arnheim N; Nitecki D; McCormick F
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5280-4. PubMed ID: 3927300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dibutyryl cAMP inhibits expression of transformation-related properties in Kirsten murine sarcoma virus transformed Balb/c-3T3 cells despite continued presence of p21v-Ki-ras.
    Ridgway AA; De Vouge MW; Mukherjee BB
    Biochem Cell Biol; 1988 Jan; 66(1):54-65. PubMed ID: 2835972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular cloning of the temperature-sensitive 371 Kirsten murine sarcoma virus and expression in Escherichia coli of the mutant and wild-type viral Kirsten ras p21 proteins.
    Stein RB; Tai JY; Scolnick EM
    J Virol; 1986 Nov; 60(2):782-6. PubMed ID: 3022010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities.
    Lacal JC; Anderson PS; Aaronson SA
    EMBO J; 1986 Apr; 5(4):679-87. PubMed ID: 3011420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of quantitative liquid competition radioimmunoassays for the ras oncogene and proto-oncogene p21 products.
    Caruso A; Schlom J; Vilasi V; Weeks MO; Hand PH
    Int J Cancer; 1986 Oct; 38(4):587-95. PubMed ID: 3489681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the Kirsten ras viral and human proteins in Escherichia coli.
    Nakano ET; Rao MM; Perucho M; Inouye M
    J Virol; 1987 Feb; 61(2):302-7. PubMed ID: 3027361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for ras proto-oncogene function during serum-stimulated growth of NIH 3T3 cells.
    Mulcahy LS; Smith MR; Stacey DW
    Nature; 1985 Jan 17-23; 313(5999):241-3. PubMed ID: 3918269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ras oncogene product p21 is not a regulatory component of adenylate cyclase.
    Beckner SK; Hattori S; Shih TY
    Nature; 1985 Sep 5-11; 317(6032):71-2. PubMed ID: 3929144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Stacey DW; Kung HF
    Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation.
    Hinds P; Finlay C; Levine AJ
    J Virol; 1989 Feb; 63(2):739-46. PubMed ID: 2642977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative biochemical properties of p21 ras molecules coded for by viral and cellular ras genes.
    Papageorge A; Lowy D; Scolnick EM
    J Virol; 1982 Nov; 44(2):509-19. PubMed ID: 6292515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse cells contain two distinct ras gene mRNA species that can be translated into a p21 onc protein.
    Ellis RW; DeFeo D; Furth ME; Scolnick EM
    Mol Cell Biol; 1982 Nov; 2(11):1339-45. PubMed ID: 6131379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mitogenic/oncogenic p21 Ki-RAS protein stimulates adenylate cyclase activity early in the G1 phase of NRK rat kidney cells.
    Franks DJ; Whitfield JF; Durkin JP
    Biochem Biophys Res Commun; 1985 Oct; 132(2):780-6. PubMed ID: 3904756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function.
    Lacal JC; Aaronson SA
    Proc Natl Acad Sci U S A; 1986 Aug; 83(15):5400-4. PubMed ID: 2426696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.
    Radinsky R; Flickinger KS; Kosir MA; Zardi L; Culp LA
    Cancer Res; 1990 Jul; 50(14):4388-400. PubMed ID: 2163749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for c-ras proteins during viral oncogene transformation.
    Smith MR; DeGudicibus SJ; Stacey DW
    Nature; 1986 Apr 10-16; 320(6062):540-3. PubMed ID: 2938016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation.
    Jelinek MA; Hassell JA
    Oncogene; 1992 Sep; 7(9):1687-98. PubMed ID: 1380149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.